Last Price
159.68
Today's Change
+15.12 (10.46%)
Day's Change
152.19 - 160.80
Trading Volume
1,203,671
Market Cap
5 Billion
Shares Outstanding
33 Million
Avg Volume
819,347
Avg Price (50 Days)
155.55
Avg Price (200 Days)
116.09
PE Ratio
3992.13
EPS
0.04
Earnings Announcement
04-Nov-2024
Previous Close
144.56
Open
155.22
Day's Range
152.19 - 160.8
Year Range
36.42 - 177.37
Trading Volume
1,204,931
1 Day Change
10.47%
5 Day Change
-3.79%
1 Month Change
-9.33%
3 Month Change
8.03%
6 Month Change
115.44%
Ytd Change
107.92%
1 Year Change
180.59%
3 Year Change
411.65%
5 Year Change
574.06%
10 Year Change
614.15%
Max Change
614.15%
No result.
Sector: Healthcare - Healthcare
Industry: Medical Devices
Description:
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.